These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 26173563

  • 1. Investigation Into Efficiency of a Novel Glycol Chitosan-Bestatin Conjugate to Protect Thymopoietin Oligopeptides From Enzymatic Degradation.
    Zhang Y, Feng J, Cui L, Zhang Y, Li W, Li C, Shi N, Chen Y, Kong W.
    J Pharm Sci; 2016 Feb; 105(2):828-837. PubMed ID: 26173563
    [Abstract] [Full Text] [Related]

  • 2. Enzymatic cleavage of thymopoietin oligopeptides by pancreatic and intestinal brush-border enzymes.
    Heizmann J, Langguth P, Biber A, Oschmann R, Merkle HP, Wolffram S.
    Peptides; 1996 Feb; 17(7):1083-9. PubMed ID: 8959740
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, Characterization and In Vitro Evaluation of a Novel Glycol Chitosan-EDTA Conjugate to Inhibit Aminopeptidase-Mediated Degradation of Thymopoietin Oligopeptides.
    Feng J, Chen Y, Li F, Cui L, Shi N, Kong W, Zhang Y.
    Molecules; 2017 Jul 26; 22(8):. PubMed ID: 28933740
    [Abstract] [Full Text] [Related]

  • 4. Nasal epithelial permeation of thymotrinan (TP3) versus thymocartin (TP4): competitive metabolism and self-enhancement.
    Schmidt MC, Rubas W, Merkle HP.
    Pharm Res; 2000 Feb 26; 17(2):222-8. PubMed ID: 10751039
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic possibilities of thymopoietin fragments (TP3 and TP4) based on experimental animal models.
    Dénes L, Szende B, Hajós G, Szporny L, Lapis K.
    Drugs Exp Clin Res; 1987 Feb 26; 13(5):279-87. PubMed ID: 3500029
    [Abstract] [Full Text] [Related]

  • 6. The slow, tight binding of bestatin and amastatin to aminopeptidases.
    Wilkes SH, Prescott JM.
    J Biol Chem; 1985 Oct 25; 260(24):13154-62. PubMed ID: 2865258
    [Abstract] [Full Text] [Related]

  • 7. Use of azidobestatin as a photoaffinity label to identify the active site peptide of leucine aminopeptidase.
    Taylor A, Peltier CZ, Jahngen EG, Laxman E, Szewczuk Z, Torre FJ.
    Biochemistry; 1992 Apr 28; 31(16):4141-50. PubMed ID: 1567860
    [Abstract] [Full Text] [Related]

  • 8. Structural and dynamic properties of thymopoietin mimetics.
    Kondratyev MS, Lunin SM, Kabanov AV, Samchenko AA, Komarov VM, Fesenko EE, Novoselova EG.
    J Biomol Struct Dyn; 2014 Apr 28; 32(11):1793-801. PubMed ID: 24024467
    [Abstract] [Full Text] [Related]

  • 9. Degradation of thymopentin by human lymphocytes: evidence for aminopeptidase activity.
    Amoscato AA, Balasubramaniam A, Alexander JW, Babcock GF.
    Biochim Biophys Acta; 1988 Jul 20; 955(2):164-74. PubMed ID: 3293664
    [Abstract] [Full Text] [Related]

  • 10. The influence of new thymopoietin derivatives on the immune response of inbred mice.
    Rajnavölgyi E, Kulics J, Szilágyvári M, Kisfaludy L, Nyéki O, Schön I, Gergely J.
    Int J Immunopharmacol; 1986 Jul 20; 8(2):167-77. PubMed ID: 3519478
    [Abstract] [Full Text] [Related]

  • 11. Bestatin analogue from Streptomyces neyagawaensis SL-387.
    Chung MC, Lee HJ, Chun HK, Lee CH, Kim SI, Kho YH.
    Biosci Biotechnol Biochem; 1996 May 20; 60(5):898-900. PubMed ID: 8704320
    [Abstract] [Full Text] [Related]

  • 12. The effect of thymopoietin 32-34 (TP3) on suramin-induced inhibition on delayed type hypersensitivity in guinea pigs.
    Dénes L, Hajós G, Szporny L, Szende B, Lapis K, Sipka S, Szegedi G.
    Immunol Invest; 1987 Jun 20; 16(4):275-9. PubMed ID: 3323037
    [Abstract] [Full Text] [Related]

  • 13. Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.
    Burley SK, David PR, Lipscomb WN.
    Proc Natl Acad Sci U S A; 1991 Aug 15; 88(16):6916-20. PubMed ID: 1871107
    [Abstract] [Full Text] [Related]

  • 14. An aminoboronic acid derivative inhibits thymopentin metabolism by mucosal membrane aminopeptidases.
    Hussain MA, Koval CA, Shenvi AB, Aungst BJ.
    Life Sci; 1990 Aug 15; 47(3):227-31. PubMed ID: 2201862
    [Abstract] [Full Text] [Related]

  • 15. 1H-NMR studies on thymopoietin-type oligopeptides--assignment of the proton resonances and investigation of conformational preferences.
    Guo W, Noszál B, Schön I, Nyéki O.
    J Pharm Biomed Anal; 1993 Jul 15; 11(7):541-7. PubMed ID: 8399527
    [Abstract] [Full Text] [Related]

  • 16. Bestatin as an experimental tool in mammals.
    Scornik OA, Botbol V.
    Curr Drug Metab; 2001 Mar 15; 2(1):67-85. PubMed ID: 11465152
    [Abstract] [Full Text] [Related]

  • 17. Copper(II) complexes of low molecular weight derivatives of thymopoietin.
    Sóvágó I, Bertalan C, Göbl L, Schón I, Nyéki O.
    J Inorg Biochem; 1994 Jul 15; 55(1):67-75. PubMed ID: 8046437
    [Abstract] [Full Text] [Related]

  • 18. Transport and metabolic pathway of thymocartin (TP4) in excised bovine nasal mucosa.
    Lang S, Langguth P, Oschmann R, Traving B, Merkle HP.
    J Pharm Pharmacol; 1996 Nov 15; 48(11):1190-6. PubMed ID: 8961171
    [Abstract] [Full Text] [Related]

  • 19. Spectroscopic and X-ray crystallographic characterization of bestatin bound to the aminopeptidase from Aeromonas (Vibrio) proteolytica.
    Stamper CC, Bienvenue DL, Bennett B, Ringe D, Petsko GA, Holz RC.
    Biochemistry; 2004 Aug 03; 43(30):9620-8. PubMed ID: 15274616
    [Abstract] [Full Text] [Related]

  • 20. Chemical synthesis and application of C-terminally 5-carboxyfluorescein-labelled thymopentin as a fluorescent probe for thymopoietin receptor.
    Onoue S, Liu B, Nemoto Y, Hirose M, Yajima T.
    Anal Sci; 2006 Dec 03; 22(12):1531-5. PubMed ID: 17159311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.